At ChangeWave Biotech Investor, we use the unmatched research capabilities of our ChangeWave Research Alliance – coupled with ongoing analysis from our colleagues at BioMedTracker – to identify the very best opportunities in the biotech world: Those where risk is kept as low as possible...and your profit opportunity is nearly unlimited. 

We will be investing together in three
distinct types of biotechs:

• The Bleeding Edge Biotechs: Early-stage companies with the greatest risk and greatest potential reward. These stocks can be your 20-to-100-baggers.
• Small Emerging Biotechs: These are companies still without revenue, but deep into the clinical trial process. Potential 10-to-20-baggers.
• Mature Biotechs: These companies have proven science and drugs – plus they're growing many times faster than traditional drug companies. Potential 5-baggers.

This is not some quick scheme to get rich overnight. While we can see – and have seen – gains of 60%-90% in a matter of months, it will take patience to reap your full rewards. But 2 years for 300% gains; 3 years for 500% gains; or 5 years for 1,000% gains is time well spent, indeed.

Here's how we'll communicate these
opportunities to you:

• Weekly Biotech Investor E-Letter, delivered to your email inbox on Thursday each week. These weekly letters will give you detailed updates on recommended companies; full buy/sell instructions; new additions to our portfolio; updates on the science behind our picks; and more.
• Biotech Investor Flash Alerts, whenever market conditions dictate or we have news about individual stocks, which you simply must hear about now.
• Biotech Investor Member-Only Website, where you can read current and past advice and updates; track our holdings; view open and closed positions; and more.

If you accept your no-risk trial subscription to ChangeWave Biotech Investor now, you pay just $1,195 for a year (that's $300 off the regular price of $1495) or $299 for 3 months.

You don't risk a penny of your subscription cost. Take 90 days to decide if it's right for you. Cancel anytime in that period – even the very last day – for a full, prompt refund. Even after that, you can cancel anytime you wish, and we'll promptly refund the full remaining balance of your subscription term.

If you select our convenient quarterly billing option, you pay just $299 now. The same credit card will be charged $299 every quarter. If you decide to end your subscription, simply give us a call and we will discontinue your service and you won't be billed another penny.

SPECIAL BONUS: Here's one more incentive to accept this offer now.

Perhaps you're itching to start thinking about biotechs now. If so, we've just completed a new Special Report, Five Biotech Stocks You Have to Own Now!, which you can read and print online immediately, once you accept this invitation. So please do it now.